Indaptus Therapeutics is trading at $3.14, up 6.08%, amid broader biotech strength.
- No company-specific announcement explaining the October 21 move was identified; XBI rose 2.10% during the regular session.
- Coverage reported a $24 million private placement issuing 20,338,974 shares, closed October 16 and announced October 20; it was not directly linked to today’s rise.
- Shares rose 8.42% October 20, their second consecutive session of gains; intraday volume data was unavailable.